DxTx provides healthcare professionals with instant access to medical calculators, clinical tools, and guideline-based recommendations at the point of care. It translates validated evidence into practical, easy-to-use tools to support real-world clinical decision-making and improve patient outcomes.

Orakle LLC

1317 Edgewater Dr

#2367 Orlando

Florida 32804.

+1 (407) 476-9889 / Email: [email protected]

Orakle LLC ©2026 All Rights ReservedTerms of Use Privacy Policy

Home
CME
FAQ
Tutorial
Terms

3-Variable Prognostic Score (3-PS) for mCRPC Treated With Radium-223

Estimates prognostic risk and median overall survival in metastatic castration-resistant prostate cancer before radium-223 treatment.

INSTRUCTIONS

The calculator assigns a 3-PS score, risk group, and associated median overall survival.

ECOG performance status*

0A

1B

2 or higherC

Prostate-specific antigen (PSA)*

ng/mL

Hemoglobin*

g/dL

Result:

Please fill out required fields.

Have feedback about this calculator?